Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Neurofibromatosis 1 4Melanoma 4Pancreatic Neoplasms 3Neurofibroma, Plexiform 3Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Rectal Neoplasms 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Bile Duct Neoplasms 2Adult Solid Neoplasm 2Uveal Melanoma 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Thymoma 1Small Cell Lung Carcinoma 1Sarcoma 1Peripheral Nervous System Diseases 1Pain 1Neuroblastoma 1Neoplasms, Nerve Tissue 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Leukemia, Promyelocytic, Acute 1Leukemia, Myeloid, Acute 1Heredodegenerative Disorders, Nervous System 1

Interventions

Cytarabine 6Idarubicin 4Vorinostat 3Tretinoin 3Etoposide 3Daunorubicin 3Azacitidine 3romidepsin 2Thioguanine 2Sorafenib 2Radiotherapy 2Mitoxantrone 2Methotrexate 2Mercaptopurine 2Lenalidomide 2Cyclophosphamide 2sargramostim 1perifosine 1octadecyl-(N,N-dimethylpiperidino-4-yl)-phosphate 1merphos 1ispinesib 1flt3 ligand protein 1entinostat 1belinostat 1Peripheral Blood Stem Cell Transplantation 1Homoharringtonine 1Filgrastim 1Drug Therapy 1Decitabine 1CK0238273 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Leukemia, Promyelocytic, Acute × AZD 6244 × Clear all
NCT00588809 2015-08-05

Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 2 Completed
47 enrolled 9 charts
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡